J.R. Rushing is a healthcare venture leader focused on expanding clinical access to regenerative therapies across emerging medical markets. Bringing decades of executive experience across healthcare manufacturing, distribution, and compliance, he builds resilient supply networks that deliver biological treatments to medical providers and patient communities.

Partnering with Israel-based RedDress, Mr. Rushing spearheads the regional expansion of ActiGraft autologous wound therapies across Jamaica and the wider Caribbean. His targeted clinical initiatives combat chronic diabetic ulcers, advancing essential limb-preservation strategies and providing modern treatment solutions to historically underserved facilities.

Through the Physicians Compliance Network, Mr. Rushing guides a portfolio focused on FDA-approved therapeutic devices, diagnostics, and infection prevention systems. Anchoring commercial innovation in community welfare, he pairs clinical distribution with active philanthropic support for civic outreach, homelessness relief, and essential community resources.